Skip to main content

Table 1 Registered clinical trials of mesenchymal stem cells in kidney transplantation (ClinicalTrial.gov, updated July 2015)

From: Mesenchymal stem cell-based therapy in kidney transplantation

NCT

Status

Title

Site

Type of MSC

Start date

NCT02409940

Recruiting

To elucidate the effect of mesenchymal stem cells on the T-cell repertoire of kidney transplant patients

Chandigarh, India

Autologous/allogeneic; BM-MSC

September 2013

NCT02387151

Recruiting

Allogeneic mesenchymal stromal cell therapy in renal transplant recipients

Leiden, Netherlands

Allogeneic; BM-MSC

March 2015

NCT02057965

Recruiting

Mesenchymal stromal cell therapy in renal recipients

Leiden, Netherlands

Autologous; BM-MSC

March 2014

NCT02012153

Recruiting

Mesenchymal stromal cells in kidney transplant recipients

Bergamo, Italy

Autologous; BM-MSC

December 2013

NCT00659620

Unknown

Mesenchymal stem cell transplantation in the treatment of chronic allograft nephropathy

Fuzhou, Fujian

Autologous; BM-MSC

May 2008

NCT00734396

Completed

Mesenchymal stem cells and subclinical rejection

Leiden, Netherlands

Autologous; BM-MSC

February 2009

NCT00752479

Terminated

Mesenchymal stem cells under basiliximab/low dose RATG to induce renal transplant tolerance

Bergamo, Italy

Autologous; BM-MSC

May 2008

NCT00658073

Completed

Induction therapy with autologous mesenchymal stem cells for kidney allografts

Fuzhou, Fujian

Autologous; BM-MSC

March 2008

NCT01429038

Recruiting

Mesenchymal stem cells after renal or liver transplantation

Liege, Belgium

Allogeneic; BM-MSC

February 2012

  1. BM-MSC bone marrow-derived mesenchymal stem cell, MSC mesenchymal stem cell, NCT ClinicalTrials.gov identifier, RATG rabbit antithymocyte globulin